{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20190226",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "57823",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209296s003lbl.pdf",
              "date": "20190227",
              "type": "Label"
            },
            {
              "id": "57833",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/209296Orig1s003ltr.pdf",
              "date": "20190228",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "15",
          "submission_status": "AP",
          "submission_status_date": "20240305",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "77716",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/209296Orig1s015ltr.pdf",
              "date": "20240305",
              "type": "Letter"
            },
            {
              "id": "77721",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209296Orig1s015lbl.pdf",
              "date": "20240305",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20220314",
          "review_priority": "N/A",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "70522",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/209296Orig1s008ltr.pdf",
              "date": "20220315",
              "type": "Letter"
            },
            {
              "id": "70796",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209296Orig1s008lbl.pdf",
              "date": "20220420",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20191021",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "60630",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/209296Orig1s004ltr.pdf",
              "date": "20191022",
              "type": "Letter"
            },
            {
              "id": "60632",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209296s004lbl.pdf",
              "date": "20191022",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20171109",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "50368",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209296Orig1s000ltr.pdf",
              "date": "20171113",
              "type": "Letter"
            },
            {
              "id": "50385",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209296s000lbl.pdf",
              "date": "20171113",
              "type": "Label"
            },
            {
              "id": "52881",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209296Orig1s000TOC.html",
              "date": "20180309",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA209296",
      "sponsor_name": "HERON THERAPS INC",
      "openfda": {
        "application_number": [
          "NDA209296"
        ],
        "brand_name": [
          "CINVANTI"
        ],
        "generic_name": [
          "APREPITANT"
        ],
        "manufacturer_name": [
          "Heron Therapeutics, Inc."
        ],
        "product_ndc": [
          "47426-201"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "APREPITANT"
        ],
        "rxcui": [
          "1995150",
          "1995155"
        ],
        "spl_id": [
          "94c147fd-c8bd-428c-911b-f1aba4ab8729"
        ],
        "spl_set_id": [
          "4c218d3a-a508-4abc-9ed8-a6e8e191d1b4"
        ],
        "package_ndc": [
          "47426-201-01"
        ],
        "nui": [
          "N0000010262",
          "N0000175786",
          "N0000182141",
          "N0000185507",
          "N0000185506"
        ],
        "pharm_class_moa": [
          "Neurokinin 1 Antagonists [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Cytochrome P450 2C9 Inducers [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]"
        ],
        "pharm_class_epc": [
          "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "1NF15YR6UY"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "CINVANTI",
          "active_ingredients": [
            {
              "name": "APREPITANT",
              "strength": "130MG/18ML (7.2MG/ML)"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "EMULSION",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}